These backgrounders provide you with more in-depth information on various topics related to Victoza® (liraglutide) such as diabetes in general, diabetes treatment, and an overview of the Liraglutide Effect and Action in Diabetes (LEAD™) clinical trials.
Novo Nordisk is a global healthcare company with 88 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs approximately 32,500 employees in 74 countries, and markets its products in 179 countries.
 | Novo Nordisk in the USA |
 | Novo Nordisk in Denmark |
Or choose:
